Age Related Macular Degeneration and the Macula Lens

by: Dr Amir Hamid

 This week I was in Budapest to learn more about the Scharioth Macula Lens and how it can help patients who have sight loss from AMD.
Age Related Macular Degeneration (AMD)
AMD is a degenerative condition affecting the central part of the retina called the macula. This central sight loss profoundly affects reading ability and many other important tasks of daily living.
There are 2 main types of AMD: Dry and Wet

Dry AMD 
The most common form of AMD has no available treatment to prevent development or progression. There is evidence that nutritional supplements can slow down progression. However, Dry AMD progresses slowly over many years leading to a blank patch in central vision.
This form of AMD is rapidly progressive but can be treated with anti-VEGF injections. Despite this central vision loss may still occur.
Visual Aids
There are many visual aids to help patients to regain reading ability with the use of magnification. However, many of these aids can be bulky or not easily moved from location to location. Many patients are also not comfortable in displaying the fact that they have a visual disability in public.
The Scharioth Macula Lens (SML): The Magnifier in the Eye
Is an add on intraocular lens which acts as a magnifier in the eye. A scientific paper has been published in the respected Journal of Cataract and Refractive Surgery demonstrating its safety and efficacy.
In addition it is much more affordable than competing technologies available with significantly less invasive surgery with more rapid visual recovery.
In Budapest I listened and spoke to Prof Scharioth himself about the scientific basis of the lens, its development and safety profile but most importantly how satisfied his patients have been. I am convinced it has much to offer in the cases of motivated individuals who want to continue to maintain an active lifestyle.
I will now be offering the SML in London and the SE of England.
For more information about AMD:
For more information about the SML: